二次性慢性脊髓损伤的药理管理:系统性审查

Filippo Migliorini1,2, Federico Cocconi2, Luise Schäfer1

  • 1Department of Life Sciences, Health, and Health Professions, Link Campus University, Via del Casale di S. Pio V, 44, 00165 Rome, Italy.

British medical bulletin
|September 2, 2024
PubMed
概括

管理二次慢性脊髓损伤 (SCI) 是一个挑战. 本综述分析了当前的药理选择,强调了4-aminopyridine和抗性药物,如tizanidine和baclofen,以寻找潜在的益处.